You are here

BioNTech

BioNTech wins up to $90 mln in funding for mpox vaccine development

BioNTech wins up to $90 mln in funding for mpox vaccine development

Yahoo/Reuters

Flag link:

Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?

Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?

Forbes

Moderna Therapeutics

Flag link:

Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines

Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines

Fierce Pharma

Moderna Therapeutics

Flag link:

Pfizer and BioNTech’s COVID-19 vaccine for children receives EU recommendation

Pfizer and BioNTech’s COVID-19 vaccine for children receives EU recommendation

Biopharma Reporter

Flag link:

Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation

Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation

Fierce Pharma

Moderna Therapeutics

Flag link:

BioNTech sticks with COVID vaccine outlook amid sharp revenue declines

BioNTech sticks with COVID vaccine outlook amid sharp revenue declines

Medical Marketing and Media

Flag link:

Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data

Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data

Fierce Biotech

Flag link:

Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech

Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech

Fierce Pharma

Moderna Therapeutics

Flag link:

Will US Pharma See Lawsuits over COVID Vaccine Side Effects?

Will US Pharma See Lawsuits over COVID Vaccine Side Effects?

BioSpace

Flag link:

BioNTech's OncoC4 partnership off to good start with mid-stage trial results

BioNTech's OncoC4 partnership off to good start with mid-stage trial results

Yahoo/Reuters

clinical trials

metastatic non-small cell lung cancer

Flag link:

ASCO puts spotlight on advancing antibody-drug conjugate pipeline

ASCO puts spotlight on advancing antibody-drug conjugate pipeline

BioPharma Dive

antibody-drug conjugate

Flag link:

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

Medical Marketing and Media

Flag link:

BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit

BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit

Yahoo/Reuters

pancreatic cancer

Flag link:

Biopharma Bets Big on Antibody-Drug Conjugates

Biopharma Bets Big on Antibody-Drug Conjugates

BioSpace

antibody-drug conjugate

Bristol Myers Squibb

Flag link:

Cash-rich BioNTech broadens scope as COVID shot sales slide

Cash-rich BioNTech broadens scope as COVID shot sales slide

Yahoo/Reuters

Flag link:

Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen

Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen

Fierce Pharma

Flag link:

Pfizer accused of Covid-19 vaccine patent infringement again, this time by Arbutus and Genevant

Pfizer accused of Covid-19 vaccine patent infringement again, this time by Arbutus and Genevant

Endpoints

Flag link:

BioNTech Adds Two ADCs in Second Deal in as Many Months

BioNTech Adds Two ADCs in Second Deal in as Many Months

BioSpace

antibody-drug conjugate

Duality Biologics

Flag link:

BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal

BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal

Reuters

drug development

Flag link:

Pages